Special Advertising Section

Outpatient Surgery Logo
Outpatient Surgery Logo

Do Your Cataract Patients Hate Drops?

Make post-op compliance for cataract patients easier with Dexycu, an innovative FDA-approved steroid medication intended for injection into the posterior chamber after surgery. Dexycu contains extended release dexamethasone, which releases slowly into the ocular tissues over time, making patients much less likely to have to use drops. In a randomized, double-masked, placebo-controlled trial comparing Dexycu to vehicle, the Dexycu patients were much less likely to require additional topical medication. Dexycu kits come with a vial and a sterile syringe for withdrawing the drug and a bent cannula for injection.

For more information, call (617) 926-5000, visit www.eyepointpharma.com or click on "Learn More" below.

Related Products

Visit Facebook Visit Twitter

To receive information regarding "EyePoint Pharmaceuticals Dexycu," please enter your contact information below:

You can also Log In to have some of this information filled in for you

First name:
Last name:
Degree: (MD, RSN, etc.)
Facility name:
Professional title:
ZIP code:
Email address:

Thank you!

Your product information request has been received and we will forward information to the contact information you provided shortly.